Arthur E. Weyman Young Investigator’s Award Winners

  • 2021: Malamo Countouris, MD,University of Pittsburgh Medical Center, Pittsburgh, PA – “Association of Hypertensive Disorders of Pregnancy with Coronary Microvascular Function 8-10 Years after Delivery”
  • 2020: Ambarish Pandey, MD, MSCS, University of Texas Southwestern Medical Center, Dallas, TX – “Deep Learning Models Diastolic Dysfunction: Insights from the TOPCAT Echocardiography Sub-Study”
  • 2019: Nobuyuki Kagiyama, MD, PhD, West Virginia University Heart and Vascular Institute Innovation Center, Morgantown, WV – “Cardiac Ultrasonic Fingerprinting: A Radiomics Approach for High-Throughput Feature Phenotyping of Dysfunctional Myocardium”
  • 2018: Brandon Helfield, PhD, Sunnybrook Research Institute, Toronto, ON, Canada – “Endothelial Cell Repair Biophysics During Ultrasound and Microbubble Sonoporation:
  • 2017: Federico Moccetti, MD, Oregon Health & Science University, Portland, OR – “Ultrasound Molecular Imaging of Endothelial Activation and Platelet Adhesion in Remote Arteries after Myocardial Infarction: Implications for Reducing Risk for Remote Recurrent Atherosclerotic Events”
  • 2016: Adam Castano, MD, Columbia University, Division of Cardiology, New York, NY – “Echocardiographic Predictors of Transthyretin Cardiac Amyloidosis among Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement”
  • 2015: Sukrit Narula, BA, Icahn School of Medicine at Mount Sinai, New York, NY – “Automated Morphological and Functional Phenotyping of Human Heart with Feature Tracking of 2D Echocardiographic Images Using Machine Learning Algorithms”
  • 2014: Chi Young Shim, MD, PhD, Portland Health and Science University, Portland, OR – “Platelet Attachment to Vascular Endothelium Occurs in Both Early and Late-Stage Atherosclerosis Secondary to Dysregulation of Von Willebrand Factor: Evaluation by Contrast Ultrasound Molecular Imaging”
  • 2013: Sacha R. Bhatia, MD, MBA, Massachusetts General Hospital, Boston, MA – “An Educational Intervention Reduces the Rate of Inappropriate Transthoracic Echocardiograms in Ambulatory Care”
  • 2012: Paul J.H. Lee, MSc, St. Michael’s Hospital, Toronto, ON, Canada – “Ultrasound Mediated Anti-Apoptotic Gene Therapy for Doxorubicin Cardiomyopathy”
  • 2011: Scott M. Chadderdon, MD, Oregon Health and Science University, Portland, OR – “Impaired Capillary Function Contributes to the Development of Insulin Resistance in Lean but Activity-restricted Primates: A Study Using Contrast Ultrasound Perfusion Imaging”.
  • 2010: Shelby Kutty, MD, FASE, University of Nebraska/Creighton University Joint Division of Pediatric Cardiology, Omaha, NE – “Sonothrombolysis of Intra-Catheter Aged Venous Thrombi In-Vitro Using Microbubble Enhancement and Guided Three Dimensional Ultrasound Pulses”
  • 2009: Chad L. Carr, MS, MD, Oregon Health and Science University, Portland, OR – “Assessment of Mechanisms of Impaired Angiogenesis in Diabetes with Contrast Ultrasound Perfusion Imaging and Molecular Imaging of the Immune Response”
  • 2008: Helene Thibaualt, MD, Massachusetts General Hospital, Boston, MA – “Insulin Resistance Predisposes Mice to Adverse Left Ventricular Remodeling”
  • 2007: Beat A. Kaufmann, MD, Oregon Health & Science University, Portland, OR – “Molecular Imaging of Inflammation in Atherosclerotic Lesions: A Potential Method for Early Detection and Risk Assessment”
  • 2006: Josef Korinek, MD, Mayo Clinic College of Medicine, Rochester, MN – “Serial Changes in Segmental Strain Estimate Depleted Energy Reserves During Acute Ischemia”
  • 2005: John J. Pacella, MD, University of Pittsburgh, Pittsburgh, PA – “Myocardial Contrast Echocardiographic Assessment of Microvascular Perfusion during a New Treatment for Coronary Artery”
  • 2004: Partho P. Sengupta, MBBS, DM, FASE, Mayo Clinic, Rochester, MN – “Myocardial Fiber Direction and the Transmural Sequence of Deformation Influences Genesis of Spectral Waveforms in Doppler Myocardial Imaging”
  • 2003: Raffi H. Bekeredjian, MD, University of Texas Southwestern Medical Center at Dallas, Dallas, TX – “Time Course Evaluation of Transgene Expression after Ultrasound Targeted Microbubble Destruction”.
  • 2002: Howard Leong-Poi, MD, FASE, University of Virginia, Charlottesville, VA – “The Flow-Function Relation During Acute Myocardial Ischemia is Inviolate”.
  • 2001: Marielle Scherrer-Crosbie, PhD, MD, FASE Massachusetts General Hospital, Boston, MA – “Nitric Oxide Synthase 3 Limits Left Ventricular Remodeling After Myocardial Infarction in Mice”
  • 2000: Kevin Wei, MD, FASE, University of Virginia, Charlottesville, VA – “Reversible 99mTc-sestamibi Perfusion Defects During Pharmacologically-Induced Vasodilatation are due to Reversible Decreases in Myocardial Blood Volume and Not “Flow-mismatch”
  • 1999: Matthew P. Coggins, BA, University of Virginia, Charlottesville, VA – “Mechanisms of Microbubble Adhesion to Activated Leukocytes in Vivo: Implications for Imaging and Treatment of Inflammation”
  • 1998: Danny M. Skyba, MD, University of Virginia, Charlottesville, VA – “Microbubble Destruction By Ultrasound Results in Capillary Rupture: Adverse Bioeffects or a Possible Mechanism for In Vivo Drug Delivery?”
  • 1997: Jonathan R. Linder, MD, FASE, University of Virginia, Charlottesville, VA – “Reperfusion with Venous Blood After Cardioplegic Arrest During Bypass Surgery Results in Faster Microbubble Transit Rates Compared to Arterial Blood: Evidence for Less Endothelial Injury?”
  • 1996: Sherif F. Nagueh, MD, Baylor College of Medicine, Houston, TX – “Use of Myocardial Contrast Echocardiography in the Evaluation of Hibernating Myocardium”
  • 1994: Thomas Porter, MD, FASE, University of Nebraska Medical Center, Omaha, NE – “Visually Detectable Myocardial Uptake with Peripheral Intravenous Injections of Sonicated Dextrose Albumin Following Incubation and Inhalation with Sulfur Hexaflouride”